For the Culture By The Culture. ISSN: 3064-9331.
Ohio’s attempt to restrict intoxicating hemp sales is already facing legal resistance. A judge has blocked enforcement of key provisions, raising questions about whether the law protects consumers or reshapes the cannabis market. The case could set a precedent for how states regulate hemp derived THC products across the country.
Legal cannabis is often blamed for rising traffic deaths, but federal data tells a more complicated story. NHTSA findings, toxicology limitations, and conflicting crash studies reveal that THC presence is not a reliable measure of impairment. This investigation breaks down how flawed testing and policy shortcuts have shaped the narrative around so-called stoned driving.
Thailand blew open its cannabis market, then tried to force it back under control. This feature tracks the country’s shift from prohibition to medical legalization, decriminalization, and regulatory backlash, exposing how weak enforcement, political pressure, and rushed policy turned a reform headline into a live case study in state correction.
New York legalized cannabis and opened hundreds of stores, but regulators now warn the legal market may not produce enough weed to keep them stocked. With nearly 600 stores open and sales nearing $3 billion, the state is discovering that legalization alone does not guarantee a functioning market.
Louisiana HB 373 would create a tightly controlled adult-use cannabis pilot overseen by the Louisiana Department of Health. The bill limits participation to existing medical marijuana dispensaries, imposes permit renewal fees and a 3.5 percent wholesale assessment, and sunsets July 1, 2030, forcing lawmakers to decide whether to make legalization permanent.
Workplace Wars continues in New Jersey, where Senate Bill S3452 would protect registered medical cannabis patients from metabolite-only drug test punishment. The proposal shifts the burden to employers, requiring proof by a preponderance of the evidence that lawful medical use caused on-duty impairment, backed by specific articulable symptoms. It also keeps the written notice and three-day explanation or retest process.
